[Adjuvant cancer treatment: what benefit does the patient consider worthwhile?]
Fulltext:
97531.pdf
Embargo:
until further notice
Size:
137.0Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2011Source
Nederlands Tijdschrift voor Geneeskunde, 155, 45, (2011), pp. A3905ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Health Evidence
Radiation Oncology
Former Organization
Epidemiology, Biostatistics & HTA
Journal title
Nederlands Tijdschrift voor Geneeskunde
Volume
vol. 155
Issue
iss. 45
Page start
p. A3905
Page end
p. A3905
Subject
NCEBP 2:Evaluation of complex medical interventions ONCOL 4:Quality of Care; ONCOL 4: Quality of CareAbstract
- Adjuvant treatments can be added to primary curative cancer treatments to increase the probability of survival. However, these treatments have side effects.- Research into what additional probability of survival cancer patients require from an adjuvant treatment before they consider it worthwhile, has been carried out in hypothetical situations.- The published literature on this subject shows that the additional benefit which patients expect is small. Yet, variation in patient preferences within studies is large.- Preferences regarding additional benefit are not consistently associated with patient socio-demographic or disease characteristics.- It is very likely that new patients who face the choice of adjuvant treatment will greatly differ from each other in the benefit that they require from it.- In order to give individualized recommendations, specialists need to ask the patient which benefits and disadvantages he or she considers to be important.
This item appears in the following Collection(s)
- Academic publications [246625]
- Electronic publications [134162]
- Faculty of Medical Sciences [93367]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.